Cargando…

NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19

Detalles Bibliográficos
Autores principales: Annie, Frank H., Bates, Mark, Embrey, Sarah, Alkhouli, Mohamad, Bhatt, Deepak, Misenheimer, Jacob, George, Hannah, Gwinn, Ronald, Nanjundappa, Aravinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091226/
http://dx.doi.org/10.1016/S0735-1097(21)04431-4
_version_ 1783687435753881600
author Annie, Frank H.
Bates, Mark
Embrey, Sarah
Alkhouli, Mohamad
Bhatt, Deepak
Misenheimer, Jacob
George, Hannah
Gwinn, Ronald
Nanjundappa, Aravinda
author_facet Annie, Frank H.
Bates, Mark
Embrey, Sarah
Alkhouli, Mohamad
Bhatt, Deepak
Misenheimer, Jacob
George, Hannah
Gwinn, Ronald
Nanjundappa, Aravinda
author_sort Annie, Frank H.
collection PubMed
description
format Online
Article
Text
id pubmed-8091226
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Cardiology Foundation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80912262021-05-03 NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19 Annie, Frank H. Bates, Mark Embrey, Sarah Alkhouli, Mohamad Bhatt, Deepak Misenheimer, Jacob George, Hannah Gwinn, Ronald Nanjundappa, Aravinda J Am Coll Cardiol Spotlight on Special Topics American College of Cardiology Foundation. Published by Elsevier Inc. 2021-05-11 2021-05-03 /pmc/articles/PMC8091226/ http://dx.doi.org/10.1016/S0735-1097(21)04431-4 Text en © 2021 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Spotlight on Special Topics
Annie, Frank H.
Bates, Mark
Embrey, Sarah
Alkhouli, Mohamad
Bhatt, Deepak
Misenheimer, Jacob
George, Hannah
Gwinn, Ronald
Nanjundappa, Aravinda
NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title_full NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title_fullStr NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title_full_unstemmed NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title_short NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
title_sort no excess mortality associated with concomitant ace inhibitor or arb use in hospitalized patients with covid-19
topic Spotlight on Special Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091226/
http://dx.doi.org/10.1016/S0735-1097(21)04431-4
work_keys_str_mv AT anniefrankh noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT batesmark noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT embreysarah noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT alkhoulimohamad noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT bhattdeepak noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT misenheimerjacob noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT georgehannah noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT gwinnronald noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19
AT nanjundappaaravinda noexcessmortalityassociatedwithconcomitantaceinhibitororarbuseinhospitalizedpatientswithcovid19